{"id":758272,"date":"2023-05-11T20:21:34","date_gmt":"2023-05-12T00:21:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/"},"modified":"2023-05-11T20:21:34","modified_gmt":"2023-05-12T00:21:34","slug":"ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/","title":{"rendered":"Ambrx to Present at JMP Securities Life Sciences and RBC Capital Markets Global Healthcare Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN DIEGO, May  11, 2023  (GLOBE NEWSWIRE) &#8212; Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), today announced that Daniel J. O\u2019Connor, Chief Executive Officer and President of Ambrx, will present a corporate overview at the JMP Securities Life Sciences Conference and RBC Capital Markets Global Healthcare Conference taking place in New York City on May 16<sup>th<\/sup> and 17<sup>th<\/sup>, respectively. The presentations will focus on the status of Ambrx\u2019s clinical development strategy and an update on the progress of its lead clinical candidates, ARX788 and ARX517.<\/p>\n<p>Presentation details are below:<\/p>\n<p>\n        <strong>JMP Securities Life Sciences Conference: <\/strong><br \/>\n        <br \/>Date: Tuesday, May 16, 2023<br \/>Time: 2:30pm \u2013 3:00pm ET<\/p>\n<p>\n        <strong>RBC Capital Markets Global Healthcare Conference: <\/strong><br \/>\n        <br \/>Date: Wednesday, May 17, 2023<br \/>Time: 10:30am \u2013 10:55am ET<\/p>\n<p>\n        <strong>About Ambrx Biopharma Inc.<\/strong>\n      <\/p>\n<p>Ambrx is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop next generation antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system. Ambrx is advancing a focused portfolio of clinical and preclinical programs designed to optimize efficacy and safety in multiple cancer indications, including ARX517, its proprietary antibody-drug conjugates (ADC) targeting the prostate-specific membrane antigen (PSMA) and ARX788, its proprietary ADC targeting HER2. In addition, Ambrx has preclinical and clinical collaborations with multiple partners on drug candidates generated using Ambrx technology. Ambrx spun out of The Scripps Research Institute in 2003 and has several other product candidates involving ADCs and other aspects of Ambrx\u2019s protein engineering technology. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6vjUqg7bvSJhN_pp7KZFXRinGOABTwxmXPgVBtt-panIqmxnLJIueLFPGAu1fJsYADZvTc5ozirJjRMvz0iQ4A==\" rel=\"nofollow noopener\" target=\"_blank\">www.ambrx.com<\/a>. Ambrx routinely posts information that may be important to investors on its website.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p>This press release includes certain \u201cforward-looking statements\u201d intended to qualify for the \u201csafe harbor\u201d from liability established by the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements may be identified by the words \u201cintend,\u201d \u201cplan,\u201d and similar expressions. Forward-looking statements are based on Ambrx\u2019s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, those risks and uncertainties associated with: the continuing impact of the COVID-19 pandemic and other public health-related risks and events on Ambrx\u2019s business, operations, strategy, goals and anticipated milestones; Ambrx\u2019s ability to execute on its strategy including with respect to the timing of its R&amp;D efforts, initiation of clinical trials and other anticipated milestones; risks associated with development and marketing approval of novel therapeutics, including potential delays in clinical trials and regulatory submissions and the fact that future clinical trial results\/data may not be consistent with interim, initial or preliminary results\/data or results\/data from prior preclinical studies or clinical trials; Ambrx\u2019s ability to fund operations as anticipated; and the additional risks and uncertainties set forth more fully under the caption \u201cRisk Factors\u201d in Ambrx\u2019s Quarterly Report on Form 10-Q filed with the SEC on May 11, 2023, and elsewhere in Ambrx\u2019s filings and reports with the SEC. Forward-looking statements contained in this press release are made as of this date, and Ambrx undertakes no duty to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable law. <\/p>\n<p align=\"justify\">\n        <strong>Contacts<\/strong>\n      <\/p>\n<p align=\"justify\">INVESTORS<br \/>Mike Moyer<br \/>LifeSci Advisors<br \/>617-308-4306<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ITs5mTcL5cJ0eig3YGrb9iUmIbbxi13RWbijHrgh43kEbyvH-tGoi57acJWpt1b_D8wo4Be3Om46n8mw_3Xmp7OeceZYcC_T5eHd97awyRPv0kZEiwFP_IwP8m1e6g9L\" rel=\"nofollow noopener\" target=\"_blank\">mmoyer@lifesciadvisors.com<\/a><\/p>\n<p align=\"justify\">MEDIA<br \/>Mike Tattory<br \/>Account Supervisor\u00a0<br \/>LifeSci Communications\u00a0<br \/>609-802-6265<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8TEu9dDneFRFsDixUfAJQ0yYicAuJGwvGlv_cKrBFD2h49oJkNCLqgByFciaMYbDViXqnlaD0dcT36M0qM4y1Q==\" rel=\"nofollow noopener\" target=\"_blank\">media@ambrx.com<\/a>\u00a0<\/p>\n<p align=\"justify\">Source: Ambrx Biopharma Inc.<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzNzgxMiM1NTkxMTg3IzIyNTIyMTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NzU2OWRjMmYtNDE5NS00MjY0LTg2MDktMWY3YTBlNWQxNzFlLTEyNjM3NjU=\/tiny\/Ambrx-Biopharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) &#8212; Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), today announced that Daniel J. O\u2019Connor, Chief Executive Officer and President of Ambrx, will present a corporate overview at the JMP Securities Life Sciences Conference and RBC Capital Markets Global Healthcare Conference taking place in New York City on May 16th and 17th, respectively. The presentations will focus on the status of Ambrx\u2019s clinical development strategy and an update on the progress of its lead clinical candidates, ARX788 and ARX517. Presentation details are below: JMP Securities Life Sciences Conference: Date: Tuesday, May 16, 2023Time: 2:30pm \u2013 3:00pm ET RBC Capital Markets Global Healthcare Conference: Date: Wednesday, May 17, 2023Time: 10:30am \u2013 10:55am ET About Ambrx &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ambrx to Present at JMP Securities Life Sciences and RBC Capital Markets Global Healthcare Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-758272","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ambrx to Present at JMP Securities Life Sciences and RBC Capital Markets Global Healthcare Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ambrx to Present at JMP Securities Life Sciences and RBC Capital Markets Global Healthcare Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) &#8212; Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), today announced that Daniel J. O\u2019Connor, Chief Executive Officer and President of Ambrx, will present a corporate overview at the JMP Securities Life Sciences Conference and RBC Capital Markets Global Healthcare Conference taking place in New York City on May 16th and 17th, respectively. The presentations will focus on the status of Ambrx\u2019s clinical development strategy and an update on the progress of its lead clinical candidates, ARX788 and ARX517. Presentation details are below: JMP Securities Life Sciences Conference: Date: Tuesday, May 16, 2023Time: 2:30pm \u2013 3:00pm ET RBC Capital Markets Global Healthcare Conference: Date: Wednesday, May 17, 2023Time: 10:30am \u2013 10:55am ET About Ambrx &hellip; Continue reading &quot;Ambrx to Present at JMP Securities Life Sciences and RBC Capital Markets Global Healthcare Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-12T00:21:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzNzgxMiM1NTkxMTg3IzIyNTIyMTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ambrx to Present at JMP Securities Life Sciences and RBC Capital Markets Global Healthcare Conferences\",\"datePublished\":\"2023-05-12T00:21:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\\\/\"},\"wordCount\":574,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzNzgxMiM1NTkxMTg3IzIyNTIyMTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\\\/\",\"name\":\"Ambrx to Present at JMP Securities Life Sciences and RBC Capital Markets Global Healthcare Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzNzgxMiM1NTkxMTg3IzIyNTIyMTI=\",\"datePublished\":\"2023-05-12T00:21:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzNzgxMiM1NTkxMTg3IzIyNTIyMTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzNzgxMiM1NTkxMTg3IzIyNTIyMTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ambrx to Present at JMP Securities Life Sciences and RBC Capital Markets Global Healthcare Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ambrx to Present at JMP Securities Life Sciences and RBC Capital Markets Global Healthcare Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Ambrx to Present at JMP Securities Life Sciences and RBC Capital Markets Global Healthcare Conferences - Market Newsdesk","og_description":"SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) &#8212; Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), today announced that Daniel J. O\u2019Connor, Chief Executive Officer and President of Ambrx, will present a corporate overview at the JMP Securities Life Sciences Conference and RBC Capital Markets Global Healthcare Conference taking place in New York City on May 16th and 17th, respectively. The presentations will focus on the status of Ambrx\u2019s clinical development strategy and an update on the progress of its lead clinical candidates, ARX788 and ARX517. Presentation details are below: JMP Securities Life Sciences Conference: Date: Tuesday, May 16, 2023Time: 2:30pm \u2013 3:00pm ET RBC Capital Markets Global Healthcare Conference: Date: Wednesday, May 17, 2023Time: 10:30am \u2013 10:55am ET About Ambrx &hellip; Continue reading \"Ambrx to Present at JMP Securities Life Sciences and RBC Capital Markets Global Healthcare Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-12T00:21:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzNzgxMiM1NTkxMTg3IzIyNTIyMTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ambrx to Present at JMP Securities Life Sciences and RBC Capital Markets Global Healthcare Conferences","datePublished":"2023-05-12T00:21:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/"},"wordCount":574,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzNzgxMiM1NTkxMTg3IzIyNTIyMTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/","name":"Ambrx to Present at JMP Securities Life Sciences and RBC Capital Markets Global Healthcare Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzNzgxMiM1NTkxMTg3IzIyNTIyMTI=","datePublished":"2023-05-12T00:21:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzNzgxMiM1NTkxMTg3IzIyNTIyMTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzNzgxMiM1NTkxMTg3IzIyNTIyMTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ambrx-to-present-at-jmp-securities-life-sciences-and-rbc-capital-markets-global-healthcare-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ambrx to Present at JMP Securities Life Sciences and RBC Capital Markets Global Healthcare Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/758272","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=758272"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/758272\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=758272"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=758272"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=758272"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}